TMAO and Gut Microbial-Derived Metabolites TML and γBB Are Not Associated with Thrombotic Risk in Patients with Venous Thromboembolism.
Marina CanyellesMelania PlazaNoemí RotllanDolors LlobetJosep JulveSergi MojalMaribel Diaz-RicartJosé Manuel SoriaJoan Carles Escolà-GilMireia TondoFrancisco Blanco-VacaJoan Carles SoutoPublished in: Journal of clinical medicine (2022)
No differences were found regarding TMAO, γBB, and TML concentrations between the control and VTE groups. Some correlations were found; however, they were mild or went in the opposite direction of what would be expected if TMAO and its derivatives were related to VTE risk.